dexmedetomidine has been researched along with Lung Injury, Ventilator-Induced in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Q; Ma, F; Sun, L; Wang, M; Zhang, B; Zhang, X | 1 |
| Nie, Y; Shan, SQ; Wang, BQ; Wang, L; Yu, J; Zhu, CH | 1 |
| Chen, H; Hou, Y; Liu, D; Sun, X; Wang, H; Wang, Y; Wu, J; Yang, X; Yi, W; Yu, J; Yu, X | 1 |
| Chen, C; Chen, K; Peng, M; Wang, Y; Zhang, F; Zhang, Z | 1 |
| Ho, ST; Sheen, MJ | 1 |
| Huang, CJ; Tsai, PS; Yang, CL | 1 |
| Ding, N; Hu, XG; Liao, YL; Ruan, XC; She, SZ; Yu, L | 1 |
7 other study(ies) available for dexmedetomidine and Lung Injury, Ventilator-Induced
| Article | Year |
|---|---|
Dexmedetomidine attenuates ventilator-induced lung injury in rats by up-regulating NLRC3.
Topics: Animals; Bronchoalveolar Lavage Fluid; Dexmedetomidine; Rats; Rats, Sprague-Dawley; Tidal Volume; Ventilator-Induced Lung Injury | 2020 |
Dexmedetomidine reduces ventilator-induced lung injury via ERK1/2 pathway activation.
Topics: Animals; bcl-2 Homologous Antagonist-Killer Protein; Bronchoalveolar Lavage Fluid; Cytokines; Dexmedetomidine; Disease Models, Animal; Lung; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; NF-kappa B; Pneumonia; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Ventilator-Induced Lung Injury | 2020 |
Dexmedetomidine reduces ventilator-induced lung injury (VILI) by inhibiting Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB signaling pathway.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cytokines; Dexmedetomidine; Humans; Inflammation; Lung; Male; NF-kappa B; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Signal Transduction; Toll-Like Receptor 4; Ventilator-Induced Lung Injury; Yohimbine | 2018 |
Dexmedetomidine regulates inflammatory molecules contributing to ventilator-induced lung injury in dogs.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Blood Gas Analysis; Dexmedetomidine; Disease Models, Animal; Dogs; Lung; Neutrophils; NF-kappa B; Nitric Oxide Synthase Type II; Organ Size; Peroxidase; Random Allocation; Respiration, Artificial; Tumor Necrosis Factor-alpha; Ventilator-Induced Lung Injury | 2014 |
Dexmedetomidine: more than a sedative and analgesic.
Topics: Adrenergic alpha-Agonists; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents; Dexmedetomidine; Humans; Hypnotics and Sedatives; Ventilator-Induced Lung Injury | 2008 |
Effects of dexmedetomidine on regulating pulmonary inflammation in a rat model of ventilator-induced lung injury.
Topics: Adrenergic alpha-Agonists; Animals; Carbon Dioxide; Cyclooxygenase 2; Cytokines; Dexmedetomidine; Dinoprostone; Disease Models, Animal; Lung; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Oxygen; Rats; Rats, Sprague-Dawley; Ventilator-Induced Lung Injury | 2008 |
[Effects of dexmedetomidine hydrochloride on ERK1/2 activation in a rat model of ventilator-induced lung injury].
Topics: Animals; Dexmedetomidine; Extracellular Signal-Regulated MAP Kinases; Male; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Ventilator-Induced Lung Injury | 2011 |